Across its top 20 institutional holders, TEVA's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 11/100, avg. turnover score 34/100).

Quarterly Activity

Recent Activity

+$16.3B

Total Buy Value

$8.7B

Total Sell Value

New buy83

Trim205

Add242

Sold out70

325

Net Buyers

275

Net Sellers

Smart Money Convergence

TEVA does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/TEVA

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

881624209, 881624909, M8769Q136

FAQ

Who are the top institutional investors holding TEVA PHARMACEUTICAL-SP ADR (TEVA)?

Major stakeholders currently include BlackRock, Inc. ($2.0B), Harel Insurance Investments & Financial Services Ltd. ($1.4B), Phoenix Financial Ltd. ($1.3B). Based on the latest 13F filings, there are a total of 664 tracked investment funds and institutions maintaining positions in TEVA.

What is the overall institutional sentiment toward TEVA recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $264.6M, driven by 325 managers accumulating shares while 275 reduced their exposure.

Which institutions have been selling or reducing their TEVA positions?

In the latest period, 205 funds trimmed their holdings, and 70 managers completely exited their positions. The aggregate reported sell value was $8.7B.

Are there any notable investors adding TEVA to their portfolios?

Yes, buying activity remains notable. 83 institutions opened new positions in {ticker}, and 242 existing holders added to their shares. The total reported buy value for the quarter amounted to $16.3B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,605

Total reported value

$438.9B

584 institutions currently hold both TEVA and this stock

View detail

LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

601 institutions currently hold both TEVA and this stock

View detail

ABBV

Abbvie INC

Institutions Holding

4,029

Total reported value

$283.9B

572 institutions currently hold both TEVA and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access TEVA's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/TEVA

CLI

npx alphasmo stocks get TEVA

Full API & MCP documentation →